MAPT and Alzheimer disease: These DMN regions overlap with brain areas with high levels of amyloid-beta and tau protein deposition, brain atrophy, and hypometabolism in AD, which suggests that the DMN is particularly vulnerable to AD pathology (Buckner et al., 2008, Buckner et al., 2005).